ATE362359T1 - Amoxicillintrihydrat - Google Patents

Amoxicillintrihydrat

Info

Publication number: ATE362359T1
Authority: AT; Austria
Prior art keywords: trihydrate; product; amoxicillint; relates; preferably less
Prior art date: 2003-03-21

Application number

AT04722271T

Other languages

English (en)

Inventor

Jan Groenendaal

Everardus Leenderts

Van Der Does

Original Assignee

Dsm Ip Assets Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-21

Filing date

2004-03-22

Publication date

2007-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45007138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE362359(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-03-22 Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv

2007-06-15 Application granted granted Critical

2007-06-15 Publication of ATE362359T1 publication Critical patent/ATE362359T1/de

Links

150000004684 trihydrates Chemical class 0.000 title 1
HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 abstract 1
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 abstract 1
229960004920 amoxicillin trihydrate Drugs 0.000 abstract 1
HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 abstract 1
229960003324 clavulanic acid Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Cephalosporin Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT04722271T 2003-03-21 2004-03-22 Amoxicillintrihydrat ATE362359T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US45618803P	2003-03-21	2003-03-21
US45618703P	2003-03-21	2003-03-21
EP03100732		2003-03-21
EP03100731		2003-03-21

Publications (1)

Publication Number	Publication Date
ATE362359T1 true ATE362359T1 (de)	2007-06-15

Family

ID=45007138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04722271T ATE362359T1 (de)	2003-03-21	2004-03-22	Amoxicillintrihydrat

Country Status (14)

Country	Link
US (1)	US20060172987A1 (de)
EP (2)	EP1610766B1 (de)
JP (2)	JP4949826B2 (de)
CN (2)	CN1761457B (de)
AT (1)	ATE362359T1 (de)
BR (2)	BRPI0408403A (de)
CY (1)	CY1106809T1 (de)
DE (1)	DE602004006507T2 (de)
ES (1)	ES2286627T3 (de)
MX (2)	MXPA05010102A (de)
PL (1)	PL1610766T3 (de)
PT (1)	PT1610766E (de)
SI (1)	SI1610766T1 (de)
WO (3)	WO2004082661A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060172987A1 (en) *	2003-03-21	2006-08-03	Dsm Ip Assets B.V.	Amoxicillin trihydrate
US7534781B2 (en) *	2003-03-21	2009-05-19	Dsm Ip Assets B.V.	Crystalline amoxicillin trihydrate powder
ES2627217T3 (es) *	2007-05-21	2017-07-27	Toray Industries, Inc.	Partículas micropulverizadas cristalinas
US7985791B1 (en)	2008-02-22	2011-07-26	Lords Additives LLC	Incorporation of SBP and ulexite into composites
EP2778171A1 (de) *	2013-03-15	2014-09-17	Synbias Pharma Ltd.	Kristallines Monohydrat von Epirubicinhydrochlorid
CN103145733B (zh) *	2013-03-20	2014-02-26	四川省惠达药业有限公司	一种阿莫西林化合物及该化合物和克拉维酸钾的药物组合物
US9820943B2 (en) *	2013-09-03	2017-11-21	Dsm Sinochem Pharmaceuticals Netherlands B.V.	Micronized amoxicillin
CN104059086B (zh) *	2014-06-19	2016-04-13	河南牧翔动物药业有限公司	一种阿莫西林晶体及其制备方法
CN104099396B (zh) *	2014-07-22	2016-03-23	石药集团中诺药业（石家庄）有限公司	一种直通法制备阿莫西林的工艺
WO2017186864A1 (en)	2016-04-27	2017-11-02	Sandoz Ag	Enzymatic process for the production of beta-lactam antibiotics in the presence of particulate inoculum
CN109867687B (zh) *	2017-12-05	2021-08-17	上海朝瑞化工有限公司	一种高水溶性阿莫西林及其制备方法
CN111518119B (zh) *	2020-05-26	2021-12-21	联邦制药(内蒙古)有限公司	一种阿莫西林连续结晶工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5583789A (en) *	1978-12-18	1980-06-24	Bristol Myers Co	Preparation of penicillin
JPS6052751B2 (ja) *	1981-04-21	1985-11-21	富山化学工業株式会社	新規な結晶形を有するセフアレキシン１水和物
WO1994017800A1 (en) *	1993-02-15	1994-08-18	Gist-Brocades B.V.	AN IMPROVED β-LACTAM ANTIBIOTIC COMPOSITION
GB9423459D0 (en) *	1994-11-21	1995-01-11	Biochemie Gmbh	Silylation process
TWI225402B (en) *	1996-03-13	2004-12-21	Biochemie Gmbh	Auxiliary-free agglomerates
TR200000529T2 (tr) *	1997-08-29	2000-08-21	Dsm N.V.	İçinde eksipiyan olmayan granüller
US20020137926A1 (en) *	1998-06-01	2002-09-26	Smithkline Beecham Corporation	Process for preparing crystalline salts of amoxycillin
MXPA01009808A (es) *	1999-04-01	2002-04-24	Dsm Nv	Aglomerados por cristalizacion.
AT412213B (de) *	2000-05-30	2004-11-25	Sandoz Ag	Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US20060172987A1 (en) *	2003-03-21	2006-08-03	Dsm Ip Assets B.V.	Amoxicillin trihydrate

2004
- 2004-03-19 US US10/548,189 patent/US20060172987A1/en not_active Abandoned
- 2004-03-19 MX MXPA05010102A patent/MXPA05010102A/es active IP Right Grant
- 2004-03-19 MX MXPA05010104A patent/MXPA05010104A/es active IP Right Grant
- 2004-03-19 BR BRPI0408403-9A patent/BRPI0408403A/pt not_active Application Discontinuation
- 2004-03-19 BR BRPI0408568-0A patent/BRPI0408568A/pt not_active Application Discontinuation
- 2004-03-19 WO PCT/EP2004/002989 patent/WO2004082661A1/en not_active Ceased
- 2004-03-19 CN CN2004800075002A patent/CN1761457B/zh not_active Expired - Lifetime
- 2004-03-19 JP JP2006504788A patent/JP4949826B2/ja not_active Expired - Lifetime
- 2004-03-19 WO PCT/EP2004/003031 patent/WO2004082662A1/en not_active Ceased
- 2004-03-19 JP JP2006504807A patent/JP4949827B2/ja not_active Expired - Lifetime
- 2004-03-19 CN CN201110051058.5A patent/CN102260278B/zh not_active Expired - Lifetime
- 2004-03-22 EP EP04722271A patent/EP1610766B1/de not_active Expired - Lifetime
- 2004-03-22 PL PL04722271T patent/PL1610766T3/pl unknown
- 2004-03-22 EP EP07106590A patent/EP1808166A1/de not_active Withdrawn
- 2004-03-22 WO PCT/EP2004/003053 patent/WO2004082663A1/en not_active Ceased
- 2004-03-22 SI SI200430339T patent/SI1610766T1/sl unknown
- 2004-03-22 PT PT04722271T patent/PT1610766E/pt unknown
- 2004-03-22 AT AT04722271T patent/ATE362359T1/de active
- 2004-03-22 DE DE602004006507T patent/DE602004006507T2/de not_active Expired - Lifetime
- 2004-03-22 ES ES04722271T patent/ES2286627T3/es not_active Expired - Lifetime
2007
- 2007-08-09 CY CY20071101065T patent/CY1106809T1/el unknown

Also Published As

Publication number	Publication date
JP4949826B2 (ja)	2012-06-13
SI1610766T1 (sl)	2007-10-31
JP2006520765A (ja)	2006-09-14
BRPI0408403A (pt)	2006-03-21
MXPA05010104A (es)	2005-11-23
DE602004006507D1 (en)	2007-06-28
PT1610766E (pt)	2007-08-01
JP4949827B2 (ja)	2012-06-13
DE602004006507T2 (de)	2008-01-31
CN1761457B (zh)	2010-05-12
ES2286627T3 (es)	2007-12-01
PL1610766T3 (pl)	2007-08-31
MXPA05010102A (es)	2005-11-23
EP1610766A1 (de)	2006-01-04
WO2004082661A1 (en)	2004-09-30
WO2004082663A1 (en)	2004-09-30
WO2004082662A1 (en)	2004-09-30
CN1761457A (zh)	2006-04-19
EP1610766B1 (de)	2007-05-16
CN102260278B (zh)	2015-05-06
US20060172987A1 (en)	2006-08-03
CY1106809T1 (el)	2012-05-23
EP1808166A1 (de)	2007-07-18
BRPI0408568A (pt)	2006-03-21
CN102260278A (zh)	2011-11-30
JP2006523188A (ja)	2006-10-12

Similar Documents

Publication	Publication Date	Title
CY1106809T1 (el)	2012-05-23	Τριενυδρη αμοξικιλλινη
BR0203040A (pt)	2003-05-27	Processo para preparação de um ácido silìcico de precipitação hidrófobo com elevado grau de brancura e absorção de umidade extremamente baixa
ATE216360T1 (de)	2002-05-15	Sulfinsäurederivate und deren herstellung und verwendung
NO20005462D0 (no)	2000-10-30	Nye fettsyreanaloger for behandling av diabetes
FI91778C (fi)	1994-08-10	Piidioksidia sisältävä tuote ja menetelmä sen valmistamiseksi
BG101713A (en)	1998-03-31	Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
TR200200649T2 (tr)	2002-07-22	Farmasötik özelliklere sahip olan yeni aminodikarboksilik asit türevleri
CO4290432A1 (es)	1996-04-17	Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
NO973291L (no)	1998-01-19	Forbedret næringspreparat oppnådd ved stöping av mais, samt fremgangsmåte for fremstilling derav
DE69813565D1 (de)	2003-05-22	Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
DE69925992D1 (de)	2005-08-04	VERFAHREN ZUR HERSTELLUNG VON 5-HYDROXYBENZO[b]THIOPHEN-3-CARBONSÄURE
BR0108446A (pt)	2005-01-11	Produtos à base de uva, fortificados com cálcio e processos para prepará-los
ATE419012T1 (de)	2009-01-15	Verwendung von 2,5-dihydroxybenzolsulfonsäure- derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion
ATE424195T1 (de)	2009-03-15	Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
CY1106686T1 (el)	2012-05-23	Μεθοδος παραγωγης παρασκευασματος χρωματος βασεως ριζας ερυθροδανου
TR199802601A2 (xx)	1999-07-21	Susuz Sodyum S�lf�r�n Haz�rlanma Y�ntemi
DE69812438D1 (de)	2003-04-24	Zusammensetzung zur herstellung von brennstoff-briketts
DE50205794D1 (de)	2006-04-20	Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
DE69801811D1 (de)	2001-10-31	Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen
DE60139391D1 (de)	2009-09-10	Ierte nukleinsäuremoleküle und deren verwendungen
BRPI0411638A (pt)	2006-08-29	produto alimentìcio e métodos de preparação de uma formulação
DE502004003801D1 (de)	2007-06-21	Füllstoff enthaltende aerogele
JPS5283737A (en)	1977-07-12	Novel carboxylic acid amide derivatives and preparation thereof
DE50105067D1 (de)	2005-02-17	Synthesezwischenprodukte zur herstellung von vitamin d-derivaten
JPS552646A (en)	1980-01-10	Oil poultice medicine

Legal Events

Date

Code

Title

Description

2007-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1610766

Country of ref document: EP